121 related articles for article (PubMed ID: 12672033)
1. Mutation analysis of DMBT1 in glioblastoma, medulloblastoma and oligodendroglial tumors.
Pang JC; Dong Z; Zhang R; Liu Y; Zhou LF; Chan BW; Poon WS; Ng HK
Int J Cancer; 2003 May; 105(1):76-81. PubMed ID: 12672033
[TBL] [Abstract][Full Text] [Related]
2. DMBT1, a new member of the SRCR superfamily, on chromosome 10q25.3-26.1 is deleted in malignant brain tumours.
Mollenhauer J; Wiemann S; Scheurlen W; Korn B; Hayashi Y; Wilgenbus KK; von Deimling A; Poustka A
Nat Genet; 1997 Sep; 17(1):32-9. PubMed ID: 9288095
[TBL] [Abstract][Full Text] [Related]
3. DMBT1 polymorphisms: relationship to malignant glioma tumorigenesis.
Sasaki H; Betensky RA; Cairncross JG; Louis DN
Cancer Res; 2002 Mar; 62(6):1790-6. PubMed ID: 11912156
[TBL] [Abstract][Full Text] [Related]
4. PTEN and DMBT1 homozygous deletion and expression in medulloblastomas and supratentorial primitive neuroectodermal tumors.
Inda MM; Mercapide J; Muñoz J; Coullin P; Danglot G; Tuñon T; Martínez-Peñuela JM; Rivera JM; Burgos JJ; Bernheim A; Castresana JS
Oncol Rep; 2004 Dec; 12(6):1341-7. PubMed ID: 15547761
[TBL] [Abstract][Full Text] [Related]
5. Analysis of loss of chromosome 10q, DMBT1 homozygous deletions, and PTEN mutations in oligodendrogliomas.
Sanson M; Leuraud P; Aguirre-Cruz L; He J; Marie Y; Cartalat-Carel S; Mokhtari K; Duffau H; Delattre JY; Hoang-Xuan K
J Neurosurg; 2002 Dec; 97(6):1397-401. PubMed ID: 12507139
[TBL] [Abstract][Full Text] [Related]
6. Expression of DMBT1, a candidate tumor suppressor gene, is frequently lost in lung cancer.
Wu W; Kemp BL; Proctor ML; Gazdar AF; Minna JD; Hong WK; Mao L
Cancer Res; 1999 Apr; 59(8):1846-51. PubMed ID: 10213490
[TBL] [Abstract][Full Text] [Related]
7. The genomic structure of the DMBT1 gene: evidence for a region with susceptibility to genomic instability.
Mollenhauer J; Holmskov U; Wiemann S; Krebs I; Herbertz S; Madsen J; Kioschis P; Coy JF; Poustka A
Oncogene; 1999 Nov; 18(46):6233-40. PubMed ID: 10597221
[TBL] [Abstract][Full Text] [Related]
8. PTEN is a target of chromosome 10q loss in anaplastic oligodendrogliomas and PTEN alterations are associated with poor prognosis.
Sasaki H; Zlatescu MC; Betensky RA; Ino Y; Cairncross JG; Louis DN
Am J Pathol; 2001 Jul; 159(1):359-67. PubMed ID: 11438483
[TBL] [Abstract][Full Text] [Related]
9. Rare mutations of the DMBT1 gene in human astrocytic gliomas.
Mueller W; Mollenhauer J; Stockhammer F; Poustka A; von Deimling A
Oncogene; 2002 Aug; 21(38):5956-9. PubMed ID: 12185598
[TBL] [Abstract][Full Text] [Related]
10. Homozygous deletion and expression of PTEN and DMBT1 in human primary neuroblastoma and cell lines.
Muñoz J; Lázcoz P; Inda MM; Nistal M; Pestaña A; Encío IJ; Castresana JS
Int J Cancer; 2004 May; 109(5):673-9. PubMed ID: 14999773
[TBL] [Abstract][Full Text] [Related]
11. DMBT1 encodes a protein involved in the immune defense and in epithelial differentiation and is highly unstable in cancer.
Mollenhauer J; Herbertz S; Holmskov U; Tolnay M; Krebs I; Merlo A; Schrøder HD; Maier D; Breitling F; Wiemann S; Gröne HJ; Poustka A
Cancer Res; 2000 Mar; 60(6):1704-10. PubMed ID: 10749143
[TBL] [Abstract][Full Text] [Related]
12. Expression of the DMBT1 gene is frequently suppressed in human lung cancer.
Takeshita H; Sato M; Shiwaku HO; Semba S; Sakurada A; Hoshi M; Hayashi Y; Tagawa Y; Ayabe H; Horii A
Jpn J Cancer Res; 1999 Sep; 90(9):903-8. PubMed ID: 10551316
[TBL] [Abstract][Full Text] [Related]
13. Molecular characterization of the porcine deleted in malignant brain tumors 1 gene (DMBT1).
Haase B; Humphray SJ; Lyer S; Renner M; Poustka A; Mollenhauer J; Leeb T
Gene; 2006 Jul; 376(2):184-91. PubMed ID: 16624504
[TBL] [Abstract][Full Text] [Related]
14. DMBT1 homozygous deletion in diffuse astrocytomas is associated with unfavorable clinical outcome.
Motomura K; Mittelbronn M; Paulus W; Brokinkel B; Keyvani K; Sure U; Wrede K; Nakazato Y; Tanaka Y; Pierscianek D; Kim YH; Mariani L; Vital A; Ohgaki H
J Neuropathol Exp Neurol; 2012 Aug; 71(8):702-7. PubMed ID: 22805772
[TBL] [Abstract][Full Text] [Related]
15. Lack of DMBT1 expression in oesophageal, gastric and colon cancers.
Mori M; Shiraishi T; Tanaka S; Yamagata M; Mafune K; Tanaka Y; Ueo H; Barnard GF; Sugimachi K
Br J Cancer; 1999 Jan; 79(2):211-3. PubMed ID: 9888459
[TBL] [Abstract][Full Text] [Related]
16. Deletion of p16 and p15 genes in brain tumors.
Jen J; Harper JW; Bigner SH; Bigner DD; Papadopoulos N; Markowitz S; Willson JK; Kinzler KW; Vogelstein B
Cancer Res; 1994 Dec; 54(24):6353-8. PubMed ID: 7987828
[TBL] [Abstract][Full Text] [Related]
17. Identification of oligodendroglioma specific chromosomal copy number changes in the glioblastoma MI-4 cell line by array-CGH and FISH analyses.
Magnani I; Moroni RF; Roversi G; Beghini A; Pfundt R; Schoenmakers EF; Larizza L
Cancer Genet Cytogenet; 2005 Sep; 161(2):140-5. PubMed ID: 16102584
[TBL] [Abstract][Full Text] [Related]
18. New deletion in low-grade oligodendroglioma at the glioblastoma suppressor locus on chromosome 10q25-26.
Maier D; Comparone D; Taylor E; Zhang Z; Gratzl O; Van Meir EG; Scott RJ; Merlo A
Oncogene; 1997 Aug; 15(8):997-1000. PubMed ID: 9285695
[TBL] [Abstract][Full Text] [Related]
19. PTEN, DMBT1, and p16 alterations in diffusely infiltrating astrocytomas.
Fan X; Muñoz J; Sanko SG; Castresana JS
Int J Oncol; 2002 Sep; 21(3):667-74. PubMed ID: 12168116
[TBL] [Abstract][Full Text] [Related]
20. A novel member of the WD-repeat gene family, WDR11, maps to the 10q26 region and is disrupted by a chromosome translocation in human glioblastoma cells.
Chernova OB; Hunyadi A; Malaj E; Pan H; Crooks C; Roe B; Cowell JK
Oncogene; 2001 Aug; 20(38):5378-92. PubMed ID: 11536051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
